Physical and Chemical Properties

Analytical Data

Product Information

Description:

Crenolanib (CP-868596) is an orally bioavailable, selective small molecule inhibitor of PDGFRα and PDGFRβ with IC50 of 0.9 and 1.8 nM respectively.

Stability and Solubility Advice:

Information concerning product stability, particularly in solution, has rarely been reported and in most cases we can only offer a general guide.
We recommend that stock solutions, once prepared, are stored aliquoted in tightly sealed vials at -20°C or below and used within 1 month.

AbMole BioScience

Products are for research use only. Not for human use. We do not sell to patients.